87 related articles for article (PubMed ID: 12390759)
1. [Role of the three-dimensional distribution of abl and bcr genes in the formation of bcr/abl fusion gene in interphase neucleus].
Zhang Q; Zhou SY; Liu XL; Niu C; Xu L; Chen SJ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):197-9. PubMed ID: 12390759
[TBL] [Abstract][Full Text] [Related]
2. [Influence of irradiation on the dynamic three-dimension distribution of abl and bcr genes in the interphase nuclei of IM-9 cell].
Zhang Q; Zhou SY; Liu XL; Niu C; Xu L; Chen SJ
Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):144-8. PubMed ID: 12697127
[TBL] [Abstract][Full Text] [Related]
3. Localisation and distance between ABL and BCR genes in interphase nuclei of bone marrow cells of control donors and patients with chronic myeloid leukaemia.
Lukásová E; Kozubek S; Kozubek M; Kjeronská J; Rýznar L; Horáková J; Krahulcová E; Horneck G
Hum Genet; 1997 Oct; 100(5-6):525-35. PubMed ID: 9341866
[TBL] [Abstract][Full Text] [Related]
4. Role of the BCR-ABL oncogene in human leukemia: fifteenth Richard and Hinda Rosenthal Foundation Award Lecture.
Witte ON
Cancer Res; 1993 Feb; 53(3):485-9. PubMed ID: 8425181
[No Abstract] [Full Text] [Related]
5. The influence of the cell cycle, differentiation and irradiation on the nuclear location of the abl, bcr and c-myc genes in human leukemic cells.
Bártová E; Kozubek S; Kozubek M; Jirsová P; Lukásová E; Skalníková M; Buchnícková K
Leuk Res; 2000 Mar; 24(3):233-41. PubMed ID: 10739005
[TBL] [Abstract][Full Text] [Related]
6. The nuclear topography of ABL, BCR, PML, and RARalpha genes: evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation.
Neves H; Ramos C; da Silva MG; Parreira A; Parreira L
Blood; 1999 Feb; 93(4):1197-207. PubMed ID: 9949162
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra signal-FISH.
Kim YR; Cho HI; Yoon SS; Park S; Kim BK; Lee YK; Chun H; Kim HC; Lee DS
Genes Chromosomes Cancer; 2005 May; 43(1):37-44. PubMed ID: 15723338
[TBL] [Abstract][Full Text] [Related]
8. Bcr: a negative regulator of the Bcr-Abl oncoprotein.
Wu Y; Ma G; Lu D; Lin F; Xu HJ; Liu J; Arlinghaus RB
Oncogene; 1999 Aug; 18(31):4416-24. PubMed ID: 10442632
[TBL] [Abstract][Full Text] [Related]
9. Distribution of ABL and BCR genes in cell nuclei of normal and irradiated lymphocytes.
Kozubek S; Lukásová E; Rýznar L; Kozubek M; Lisková A; Govorun RD; Krasavin EA; Horneck G
Blood; 1997 Jun; 89(12):4537-45. PubMed ID: 9192778
[TBL] [Abstract][Full Text] [Related]
10. Influence of cell fixation on chromatin topography.
Kozubek S; Lukásová E; Amrichová J; Kozubek M; Lisková A; Slotová J
Anal Biochem; 2000 Jun; 282(1):29-38. PubMed ID: 10860496
[TBL] [Abstract][Full Text] [Related]
11. Reversed BCR/ABL rearrangement detected by FISH in Philadelphia negative chronic myelocytic leukemia.
Abeliovich D; Yehuda O; Krichevsky S; Nagler A; Ben-Neriah S; Werner M; Ludkovsky O; Ben-Yehuda D
Cancer Genet Cytogenet; 1995 Jun; 81(2):115-7. PubMed ID: 7621406
[TBL] [Abstract][Full Text] [Related]
12. BCR/ABL translocation in adult acute lymphoblastic leukemia: a comparison of conventional and interphase cytogenetic studies.
So CC; Wong KF; Chung J; Kwong YL
Cancer Genet Cytogenet; 1999 Apr; 110(1):19-22. PubMed ID: 10198617
[TBL] [Abstract][Full Text] [Related]
13. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
14. The bcr-abl gene in chronic myelogenous leukaemia.
Sawyers CL
Cancer Surv; 1992; 15():37-51. PubMed ID: 1451113
[TBL] [Abstract][Full Text] [Related]
15. Rapid detection of BCR-ABL fusion genes using a novel combined LUX primer, in-cell RT-PCR and flow cytometric method.
Shi Y; Li LZ; Sun JZ; Zhang T; Peng J; Xu CG
Ann Hematol; 2008 Jan; 87(1):35-41. PubMed ID: 17846772
[TBL] [Abstract][Full Text] [Related]
16. The BCR gene and philadelphia chromosome-positive leukemogenesis.
Laurent E; Talpaz M; Kantarjian H; Kurzrock R
Cancer Res; 2001 Mar; 61(6):2343-55. PubMed ID: 11289094
[No Abstract] [Full Text] [Related]
17. Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells.
Guo XY; Cuillerot JM; Wang T; Wu Y; Arlinghaus R; Claxton D; Bachier C; Greenberger J; Colombowala I; Deisseroth AB
Oncogene; 1998 Aug; 17(7):825-33. PubMed ID: 9779999
[TBL] [Abstract][Full Text] [Related]
18. Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukemia.
Lee YK; Kim YR; Min HC; Oh BR; Kim TY; Kim YS; Cho HI; Kim HC; Lee YS; Lee DS
Cancer Genet Cytogenet; 2006 Apr; 166(1):65-73. PubMed ID: 16616113
[TBL] [Abstract][Full Text] [Related]
19. Exon-skipping in BCR/ABL is induced by ABL exon 2.
Lichty BD; Kamel-Reid S
Biochem J; 2000 May; 348 Pt 1(Pt 1):63-9. PubMed ID: 10794714
[TBL] [Abstract][Full Text] [Related]
20. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
Campbell ML; Li W; Arlinghaus RB
Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
